Implantable Device

The FDA has granted premarket approval to Sequana Medical’s alfapump implantable device for the treatment of recurrent or refractory ascites due to cirrhosis, according to a company press release.

In this edition, enrollment and dosing complete in phase 1 trial of AIV007, popular benchmarks in clinical practice guidelines and more.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, highlights keynote addresses from International Symposium on Pediatric Neuro-Oncology.

In patients with device-detected atrial high-rate episodes, treatment with edoxaban did not reduce ischemic events and increased risk for a composite of death and major bleeding compared with placebo, researchers reported.

Cardiac implantable electronic device infections are most common within the first months after a procedure, decreasing significantly after the initial 3 months, data show.

PHILADELPHIA — An endovascular brain-computer interface allowed those who are paralyzed to perform computer-based activities, according to a presenter at the American Association of Neurological Surgeons annual meeting.

B-Secur announced the launch of the FDA-cleared next generation ECG cloud-based platform for use across Holter monitors, wearables and implantable devices.

For patients on left ventricular assist device support, the development of right HF at 3 months postimplantation increased the risk for repeated hospitalization and major adverse events, researchers reported.

In patients with cardiac implantable electronic devices, an episode of atrial fibrillation lasting at least 5.5 hours raised short-term risk for ischemic stroke, according to data published in JAMA Cardiology.

In patients with ischemic stroke and no prior evidence of atrial fibrillation, implantable ECG monitoring for 12 months detected AF more often than external monitoring for 30 days, according to the results of the PER DIEM trial.